ITOS
Price
$10.29
Change
+$0.08 (+0.78%)
Updated
Jul 11 closing price
Capitalization
393.84M
26 days until earnings call
VSTM
Price
$4.68
Change
-$0.06 (-1.27%)
Updated
Jul 11 closing price
Capitalization
257.44M
Interact to see
Advertisement

ITOS vs VSTM

Header iconITOS vs VSTM Comparison
Open Charts ITOS vs VSTMBanner chart's image
iTeos Therapeutics
Price$10.29
Change+$0.08 (+0.78%)
Volume$868.44K
Capitalization393.84M
Verastem
Price$4.68
Change-$0.06 (-1.27%)
Volume$1.21M
Capitalization257.44M
ITOS vs VSTM Comparison Chart in %
Loading...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITOS vs. VSTM commentary
Jul 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITOS is a StrongBuy and VSTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 13, 2025
Stock price -- (ITOS: $10.29 vs. VSTM: $4.68)
Brand notoriety: ITOS and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITOS: 52% vs. VSTM: 48%
Market capitalization -- ITOS: $393.84M vs. VSTM: $257.44M
ITOS [@Biotechnology] is valued at $393.84M. VSTM’s [@Biotechnology] market capitalization is $257.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITOS’s FA Score shows that 1 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • ITOS’s FA Score: 1 green, 4 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, ITOS is a better buy in the long-term than VSTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITOS’s TA Score shows that 4 TA indicator(s) are bullish while VSTM’s TA Score has 5 bullish TA indicator(s).

  • ITOS’s TA Score: 4 bullish, 5 bearish.
  • VSTM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VSTM is a better buy in the short-term than ITOS.

Price Growth

ITOS (@Biotechnology) experienced а +1.08% price change this week, while VSTM (@Biotechnology) price change was -2.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.14%. For the same industry, the average monthly price growth was +16.46%, and the average quarterly price growth was +20.75%.

Reported Earning Dates

ITOS is expected to report earnings on Nov 05, 2025.

VSTM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+9.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ITOS($394M) has a higher market cap than VSTM($257M). ITOS YTD gains are higher at: 33.984 vs. VSTM (-9.381). VSTM (-145.04M) and ITOS (-146.71M) have comparable annual earnings (EBITDA) . ITOS has more cash in the bank: 520M vs. VSTM (118M). ITOS has less debt than VSTM: ITOS (5.05M) vs VSTM (76.8M). ITOS has higher revenues than VSTM: ITOS (35M) vs VSTM (10M).
ITOSVSTMITOS / VSTM
Capitalization394M257M153%
EBITDA-146.71M-145.04M101%
Gain YTD33.984-9.381-362%
P/E RatioN/AN/A-
Revenue35M10M350%
Total Cash520M118M441%
Total Debt5.05M76.8M7%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ITOSVSTM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 16 days ago
81%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDWBY4.270.03
+0.71%
BUDWEISER BREWING CO APAC LTD.
VRTK2.05N/A
N/A
Vartech Systems Inc.
BITGF15.01N/A
N/A
Biotage AB
PTRRF0.03N/A
N/A
Pointerra Ltd.
ATGFF28.53-0.04
-0.13%
AltaGas Ltd.

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with BMRN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
+0.78%
BMRN - ITOS
51%
Loosely correlated
-1.22%
IBO - ITOS
44%
Loosely correlated
+2.58%
BDTX - ITOS
44%
Loosely correlated
+4.74%
IMNM - ITOS
44%
Loosely correlated
-3.46%
RCUS - ITOS
42%
Loosely correlated
-2.20%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with ZLDAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then ZLDAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-1.16%
ZLDAF - VSTM
47%
Loosely correlated
N/A
SNSE - VSTM
47%
Loosely correlated
-10.27%
NKTX - VSTM
42%
Loosely correlated
+1.67%
IPSC - VSTM
41%
Loosely correlated
-2.90%
SYRE - VSTM
40%
Loosely correlated
-1.69%
More